Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 78 kDa gastrin-binding protein (GBP) is a high-affinity binding site for the hormone gastrin, primarily identified in the gastric mucosa and various gastrointestinal tissues (Baldwin et al., 1994, J Biol Chem). Molecular characterization has revealed that this protein is identical to the peroxisomal bifunctional enzyme, enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase (EHHADH) (UniProt Q08426). While its primary metabolic function involves the second and third steps of the peroxisomal fatty acid beta-oxidation pathway, it also localizes to the cell membrane where it may mediate the trophic effects of gastrin (He et al., 2001, Biochem J). The 78 kDa GBP is significantly overexpressed in colorectal, gastric, and pancreatic cancers, where it is thought to promote cell proliferation and tumor growth independently of the classical Cholecystokinin B receptor (CCKBR) (Smith & Watson, 2000, Aliment Pharmacol Ther). As a potential therapeutic target, research has focused on using antisense oligonucleotides or specific antibodies to inhibit its expression or activity in gastrointestinal malignancies (Baldwin, 1995, Progress in Nucleic Acid Research and Molecular Biology). However, targeting this protein poses significant safety concerns due to its essential role in systemic lipid metabolism and peroxisomal function.
Antagonism of gastrin binding to the 78 kDa GBP to inhibit gastrin-stimulated cellular proliferation in gastrointestinal tumors.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 78 kDa gastrin-binding protein (GBP).